Finding improved medicines: the role of academic-industrial collaboration

被引：24

作者：

Chin-Dusting, J

Mizrahi, J

Jennings, G

Fitzgerald, D

机构：

[1] Baker Heart Res Inst, Alfred & Baker Med Unit, Melbourne, Vic 3004, Australia

[2] F Hoffmann La Roche Ltd, CH-4070 Basel, Switzerland

[3] Mat Med, Mere Knutsford WA16 6LG, Cheshire, England

来源：

NATURE REVIEWS DRUG DISCOVERY | 2005年 / 4卷 / 11期

关键词：

D O I：

10.1038/nrd1879

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

This paper reviews models of academic-pharmaceutical industry collaboration and debates the value of such partnerships so that those contemplating an alliance can reflect a priori on the purpose, nature and process that will provide a constructive outcome. The scope is confined to the biomedical discipline, because collaborations in other fields, such as physics and engineering, have not suffered as a result of the concerns associated with biomedicine.

引用

页码：891 / 897

页数：7

共 36 条

[21] WHY COLLABORATE [J].